HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, V. Articles by Fradet, G.J. Search for Related Content PubMed PubMed Citation Articles by Chan, V. Articles by Fradet, G.J. Related Collections Valve disease

J Thorac Cardiovasc Surg 2006;131:1267-1273
© 2006 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement

Division of Cardiovascular Surgery, Department of Surgery, University of British Columbia, Vancouver, BC, Canada.

Received for publication July 12, 2005; revisions received November 21, 2005; accepted for publication November 30, 2005.

^_* Address for reprints: W. R. Eric Jamieson, MD, 486 Burrard Building, St Paul's Hospital, 1081 Burrard St, Vancouver, BC, Canada V6Z 1Y6. (Email: wrej{at}interchange.ubc.ca).

OBJECTIVE: This study was conducted to compare the composites of valve-related complications, namely reoperation, morbidity (defined as permanent neurologic or other functional impairment), and mortality, between bioprostheses and mechanical prostheses for aortic valve replacement.

METHODS: Between 1982 and 1998, 2195 bioprostheses were implanted in 2179 patients and 980 mechanical prostheses were implanted in 883 patients. Total follow-up was 16,442 years and 5740 years for bioprostheses and mechanical prostheses, respectively. Eight variables were considered as predictors of risk for the composites of valve-related complications.

RESULTS: Linearized rates for valve-related reoperation were 1.3%/patient-year and 0.3%/patient-year for bioprostheses and mechanical prostheses (P < .001), respectively. All age groups were differentiated, except >70 years. Valve-related morbidity was differentiated for all age groups and overall, for bioprostheses and mechanical protheses, was 0.4 %/patient-year and 2.1%/patient-year, respectively (P < .001). Overall valve-related mortality was 1.0%/patient-year for bioprostheses and 0.7%/patient-year for mechanical prostheses (P = .018). Age and valve-type were predictive risk factors for reoperation and morbidity, whereas age alone was predictive of mortality. Actual freedom from valve-related reoperation favored mechanical prostheses for all age groups, except 61-70 years and >70 years. Actual freedom from valve-related morbidity favored bioprostheses in all age groups, except 40 years. Actual freedom from valve-related mortality was undifferentiated in patients 51-60, 61-70, and >70 years.

CONCLUSION: No differences were observed in valve-related reoperation and mortality in patients >60 years. Comparative evaluation gives high priority for bioprostheses in patients >60 years based on improved morbidity profile. This evaluation extends this center's recommendation for bioprostheses in aortic valve replacement to include patients >60 years.

This article has been cited by other articles:

				M. L. Brown, H. V. Schaff, B. D. Lahr, C. J. Mullany, T. M. Sundt, J. A. Dearani, C. G. McGregor, and T. A. Orszulak Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prostheses. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 878 - 884. [Abstract] [Full Text] [PDF]

				C. de Vincentiis, A. B. Kunkl, S. Trimarchi, P. Gagliardotto, A. Frigiola, L. Menicanti, and M. Di Donato Aortic Valve Replacement in Octogenarians: Is Biologic Valve the Unique Solution? Ann. Thorac. Surg., April 1, 2008; 85(4): 1296 - 1301. [Abstract] [Full Text] [PDF]

				R. El Oakley, P. Kleine, and D. S. Bach Choice of Prosthetic Heart Valve in Today's Practice Circulation, January 15, 2008; 117(2): 253 - 256. [Full Text] [PDF]

				M. Ruel, V. Chan, P. Bedard, A. Kulik, L. Ressler, B. K. Lam, F. D. Rubens, W. Goldstein, P. J. Hendry, R. G. Masters, et al. Very Long-Term Survival Implications of Heart Valve Replacement With Tissue Versus Mechanical Prostheses in Adults <60 Years of Age Circulation, September 11, 2007; 116(11_suppl): I-294 - I-300. [Abstract] [Full Text] [PDF]

				M. Vicchio, A. Della Corte, M. De Feo, G. Santarpino, L. S. De Santo, G. Romano, G. Caianiello, M. Scardone, and M. Cotrufo Quality of Life After Implantation of Bileaflet Prostheses in Elderly Patients: An Anticoagulation Work Group Experience Ann. Thorac. Surg., August 1, 2007; 84(2): 459 - 465. [Abstract] [Full Text] [PDF]